Condition: Merkel Cell Carcinoma · Sponsor: Melanoma Institute Australia
The goal of this clinical trial is to test neoadjuvant dual immunotherapy in Merkel cell carcinoma with the aim to improve recurrence-free survival
This description comes directly from the study's public registry record.
Monica Osorio · + 61 2 9911 7296 · monica.osorio@melanoma.org.au
Always discuss trial participation with your own doctor first.
| Melanoma Institute Australia | Wollstonecraft, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06151236